Maternal pregnancy events and exposures and risk of hepatoblastoma

A Children's Oncology Group (COG) study

Jessica R B Musselman, Michael K. Georgieff, Julie A. Ross, Gail E. Tomlinson, James Feusner, Mark Krailo, Logan G. Spector

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Hepatoblastoma is a rare childhood liver cancer with an obscure etiology, however it is potentially associated with selected pregnancy events and hepatoblastoma risk in offspring. Methods: Adjusted unconditional logistic regression estimated odds ratios (OR) and corresponding 95% confidence intervals (CI) for self-reported pregnancy events and medication use in a sample of mothers of 383 childhood hepatoblastoma cases and 387 controls. Results: Risk of hepatoblastoma was significantly associated with maternal first trimester weight gain (OR. =. 1.02; 95% CI 1.00, 1.04 per 1. lb increase and nearly significantly with maternal multivitamin use (OR. =. 0.73; 95% CI 0.51, 1.03). Hepatoblastoma was not associated with other maternal weight changes, maternal illness or medication use during pregnancy. Conclusion: We found little evidence that maternal illness or most medication use during pregnancy are associated with hepatoblastoma in offspring.

Original languageEnglish (US)
Pages (from-to)318-320
Number of pages3
JournalCancer Epidemiology
Volume37
Issue number3
DOIs
StatePublished - Jun 1 2013

Fingerprint

Hepatoblastoma
Mothers
Pregnancy
Odds Ratio
Confidence Intervals
First Pregnancy Trimester
Liver Neoplasms
Weight Gain
Logistic Models
Weights and Measures

Keywords

  • Body weight changes
  • Case-control studies
  • Hepatoblastoma
  • Pregnancy complications
  • Self medication

Cite this

Maternal pregnancy events and exposures and risk of hepatoblastoma : A Children's Oncology Group (COG) study. / Musselman, Jessica R B; Georgieff, Michael K.; Ross, Julie A.; Tomlinson, Gail E.; Feusner, James; Krailo, Mark; Spector, Logan G.

In: Cancer Epidemiology, Vol. 37, No. 3, 01.06.2013, p. 318-320.

Research output: Contribution to journalArticle

Musselman, Jessica R B ; Georgieff, Michael K. ; Ross, Julie A. ; Tomlinson, Gail E. ; Feusner, James ; Krailo, Mark ; Spector, Logan G. / Maternal pregnancy events and exposures and risk of hepatoblastoma : A Children's Oncology Group (COG) study. In: Cancer Epidemiology. 2013 ; Vol. 37, No. 3. pp. 318-320.
@article{5a9f9b2348ff4714ac669286812a60e9,
title = "Maternal pregnancy events and exposures and risk of hepatoblastoma: A Children's Oncology Group (COG) study",
abstract = "Background: Hepatoblastoma is a rare childhood liver cancer with an obscure etiology, however it is potentially associated with selected pregnancy events and hepatoblastoma risk in offspring. Methods: Adjusted unconditional logistic regression estimated odds ratios (OR) and corresponding 95{\%} confidence intervals (CI) for self-reported pregnancy events and medication use in a sample of mothers of 383 childhood hepatoblastoma cases and 387 controls. Results: Risk of hepatoblastoma was significantly associated with maternal first trimester weight gain (OR. =. 1.02; 95{\%} CI 1.00, 1.04 per 1. lb increase and nearly significantly with maternal multivitamin use (OR. =. 0.73; 95{\%} CI 0.51, 1.03). Hepatoblastoma was not associated with other maternal weight changes, maternal illness or medication use during pregnancy. Conclusion: We found little evidence that maternal illness or most medication use during pregnancy are associated with hepatoblastoma in offspring.",
keywords = "Body weight changes, Case-control studies, Hepatoblastoma, Pregnancy complications, Self medication",
author = "Musselman, {Jessica R B} and Georgieff, {Michael K.} and Ross, {Julie A.} and Tomlinson, {Gail E.} and James Feusner and Mark Krailo and Spector, {Logan G.}",
year = "2013",
month = "6",
day = "1",
doi = "10.1016/j.canep.2012.12.005",
language = "English (US)",
volume = "37",
pages = "318--320",
journal = "Cancer Epidemiology",
issn = "1877-7821",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Maternal pregnancy events and exposures and risk of hepatoblastoma

T2 - A Children's Oncology Group (COG) study

AU - Musselman, Jessica R B

AU - Georgieff, Michael K.

AU - Ross, Julie A.

AU - Tomlinson, Gail E.

AU - Feusner, James

AU - Krailo, Mark

AU - Spector, Logan G.

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Background: Hepatoblastoma is a rare childhood liver cancer with an obscure etiology, however it is potentially associated with selected pregnancy events and hepatoblastoma risk in offspring. Methods: Adjusted unconditional logistic regression estimated odds ratios (OR) and corresponding 95% confidence intervals (CI) for self-reported pregnancy events and medication use in a sample of mothers of 383 childhood hepatoblastoma cases and 387 controls. Results: Risk of hepatoblastoma was significantly associated with maternal first trimester weight gain (OR. =. 1.02; 95% CI 1.00, 1.04 per 1. lb increase and nearly significantly with maternal multivitamin use (OR. =. 0.73; 95% CI 0.51, 1.03). Hepatoblastoma was not associated with other maternal weight changes, maternal illness or medication use during pregnancy. Conclusion: We found little evidence that maternal illness or most medication use during pregnancy are associated with hepatoblastoma in offspring.

AB - Background: Hepatoblastoma is a rare childhood liver cancer with an obscure etiology, however it is potentially associated with selected pregnancy events and hepatoblastoma risk in offspring. Methods: Adjusted unconditional logistic regression estimated odds ratios (OR) and corresponding 95% confidence intervals (CI) for self-reported pregnancy events and medication use in a sample of mothers of 383 childhood hepatoblastoma cases and 387 controls. Results: Risk of hepatoblastoma was significantly associated with maternal first trimester weight gain (OR. =. 1.02; 95% CI 1.00, 1.04 per 1. lb increase and nearly significantly with maternal multivitamin use (OR. =. 0.73; 95% CI 0.51, 1.03). Hepatoblastoma was not associated with other maternal weight changes, maternal illness or medication use during pregnancy. Conclusion: We found little evidence that maternal illness or most medication use during pregnancy are associated with hepatoblastoma in offspring.

KW - Body weight changes

KW - Case-control studies

KW - Hepatoblastoma

KW - Pregnancy complications

KW - Self medication

UR - http://www.scopus.com/inward/record.url?scp=84876334606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876334606&partnerID=8YFLogxK

U2 - 10.1016/j.canep.2012.12.005

DO - 10.1016/j.canep.2012.12.005

M3 - Article

VL - 37

SP - 318

EP - 320

JO - Cancer Epidemiology

JF - Cancer Epidemiology

SN - 1877-7821

IS - 3

ER -